EP
ABBV icon

Edgestream Partners’s AbbVie ABBV Stock Holding History

Edgestream Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-7,402
Closed -$1.61M – 939
2026
Q1 		$1.61M Sell
7,402
-58,230
-89% -$12.9M 0.05% 546
2025
Q4 		$15M Buy
65,632
+56,150
+592% +$12.8M 0.42% 13
2025
Q3 		$2.2M Sell
9,482
-57,476
-86% -$11.7M 0.06% 506
2025
Q2 		$12.4M Buy
+66,958
New +$12.4M 0.35% 34
2025
Q1 		– Sell
-13,722
Closed -$2.44M – 816
2024
Q4 		$2.44M Sell
13,722
-34,744
-72% -$6.39M 0.1% 354
2024
Q3 		$9.57M Buy
+48,466
New +$9.05M 0.42% 10
2024
Q2 		– Sell
-29,001
Closed -$5.28M – 818
2024
Q1 		$5.28M Sell
29,001
-6,273
-18% -$1.08M 0.26% 94
2023
Q4 		$5.47M Buy
35,274
+30,718
+674% +$4.48M 0.39% 16
2023
Q3 		$679K Buy
+4,556
New +$669K 0.05% 514

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Edgestream Partners's ABBV Position: Q2 2026 in Review

Edgestream Partners sold out of AbbVie (ABBV) in Q2 2026, closing a stake of 7,402 shares — an estimated $1.61M sold.

Edgestream Partners first reported a position in ABBV in Q3 2023 and held it in 9 quarters. The position peaked at $15M in Q4 2025. 4,214 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Edgestream Partners reported no remaining AbbVie position as of Q2 2026 after selling out during the quarter.
  • Edgestream Partners sold 7,402 AbbVie shares in Q2 2026, an estimated $1.61M.
  • Edgestream Partners first reported a position in AbbVie in Q3 2023 and held it in 9 quarters.
  • Edgestream Partners's AbbVie position peaked at $15M in Q4 2025.
  • 4,214 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Edgestream Partners's 13F filing for Q2 2026, filed 11 Aug 2026.